Number of the records: 1
Outcome of Treatment of Human HeLa Cervical Cancer Cells With Roscovitine Strongly Depends on the Dosage and Cell Cycle Status Prior to the Treatment
- 1.Wesierska-Gadek, J. - Borza, A. - Walzi, E. - Kryštof, Vladimír - Maurer, M. - Komina, O. - Wandl, S.
Outcome of Treatment of Human HeLa Cervical Cancer Cells With Roscovitine Strongly Depends on the Dosage and Cell Cycle Status Prior to the Treatment.
Journal of Cellular Biochemistry. Roč. 106, č. 5 (2009), s. 937-955. ISSN 0730-2312. E-ISSN 1097-4644
Impact factor: 2.935, year: 2009
http://hdl.handle.net/11104/0181463
Number of the records: 1